In November 2018, the EU-funded “AD Detect and Prevent” project kicked off, led by the Danish digital therapeutics company Brain+, pursuing the ambitious aim of developing a digital tool to improve the detection of Alzheimer’s disease (AD) prior to the possible onset of dementia and combining this with lifestyle programmes for reducing lifestyle risk related to Alzheimer’s dementia. To achieve this, the project brought together a diverse group of partners with strong expertise in brain health, dementia, clinical neuroscience, neuroimaging and patient advocacy: Brain+, University of Oxford, Aarhus University, University of Nottingham, Alzheimer Europe and the European Brain Council.

The project continued over two years.